PINCPremier, Inc.

Nasdaq premierinc.com


$ 19.62 $ 0.20 (1.03 %)    

Wednesday, 08-May-2024 15:59:56 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 19.61
$ 18.95
$ 0.00 x 0
$ 19.62 x 200
$ 18.81 - $ 19.73
$ 18.51 - $ 27.47
3,444,158
na
2.18B
$ 0.47
$ 27.13
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-06-2024 12-31-2023 10-Q
3 11-07-2023 09-30-2023 10-Q
4 08-22-2023 06-30-2023 10-K
5 05-03-2023 03-31-2023 10-Q
6 02-07-2023 12-31-2022 10-Q
7 11-01-2022 09-30-2022 10-Q
8 08-16-2022 06-30-2022 10-K
9 05-03-2022 03-31-2022 10-Q
10 02-01-2022 12-31-2021 10-Q
11 11-02-2021 09-30-2021 10-Q
12 08-17-2021 06-30-2021 10-K
13 05-04-2021 03-31-2021 10-Q
14 02-02-2021 12-31-2020 10-Q
15 11-03-2020 09-30-2020 10-Q
16 08-25-2020 06-30-2020 10-K
17 05-06-2020 03-31-2020 10-Q
18 02-05-2020 12-31-2019 10-Q
19 11-05-2019 09-30-2019 10-Q
20 08-23-2019 06-30-2019 10-K
21 05-07-2019 03-31-2019 10-Q
22 02-06-2019 12-31-2018 10-Q
23 11-07-2018 09-30-2018 10-Q
24 08-23-2018 06-30-2018 10-K
25 05-08-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 08-23-2017 06-30-2017 10-K
29 05-10-2017 03-31-2017 10-Q
30 02-07-2017 12-31-2016 10-Q
31 11-08-2016 09-30-2016 10-Q
32 08-26-2016 06-30-2016 10-K
33 05-10-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-Q
35 11-09-2015 09-30-2015 10-Q
36 08-26-2015 06-30-2015 10-K
37 05-12-2015 03-31-2015 10-Q
38 02-10-2015 12-31-2014 10-Q
39 11-12-2014 09-30-2014 10-Q
40 09-04-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-neutral-on-premier-lowers-price-target-to-22

Piper Sandler analyst Jessica Tassan maintains Premier (NASDAQ:PINC) with a Neutral and lowers the price target from $24 to ...

 canaccord-genuity-downgrades-premier-to-hold-lowers-price-target-to-21

Canaccord Genuity analyst Richard Close downgrades Premier (NASDAQ:PINC) from Buy to Hold and lowers the price target from $...

 baird-maintains-neutral-on-premier-lowers-price-target-to-22

Baird analyst Eric Coldwell maintains Premier (NASDAQ:PINC) with a Neutral and lowers the price target from $25 to $22.

 premier-q3-adj-055-beats-048-estimate-sales-34260m-beat-31851m-estimate

Premier (NASDAQ:PINC) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.48 by 14.5...

 beebe-healthcare-selects-premier-as-supply-chain-operations-strategic-partner

https://premierinc.com/newsroom/press-releases/premier-inc-announces-strategic-supply-chain-partnership-with-beebe-healthcare 

 clinical-research-collaboration-between-premier-incs-pinc-ai-applied-sciences-and-mclaren-health-care-aims-to-advance-patient-outcomes---premier

https://premierinc.com/newsroom/press-releases/clinical-research-collaboration-between-premier-inc-s-pinc-ai-applied-sciences-a...

 leerink-partners-initiates-coverage-on-premier-with-market-perform-rating-announces-price-target-of-225

Leerink Partners analyst Michael Cherny initiates coverage on Premier (NASDAQ:PINC) with a Market Perform rating and announc...

 us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

 premier-incs-pinc-ai-applied-sciences-and-datavant-collaborate-to-enable-next-generation-clinical-trials

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-pre...

 healthcare-purchasing-network-premier-launches-1b-share-buyback-program-concludes-strategic-review-process-after-q2-performance

Premier charts a strategic path with a $1.0 billion share repurchase plan through June 2025. Q2 2024 earnings: EPS $0.60, sales...

 premier-q2-2024-adj-eps-060-beats-057-estimate-sales-33475m-miss-34150m-estimate

Premier (NASDAQ:PINC) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.57 by 5.26...

 langaware-forges-transformative-collaboration-with-premier-incs-pinc-ai-applied-sciences-to-revolutionize-healthcare

Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.NEW ...

 premiers-pinc-ai-applied-sciences-and-tfs-healthscience-to-partner-to-improve-patient-outcomes-and-reduce-health-disparities-combine-tfs-capabilities-systems-and-clinical-development-expertise-with-pas-ai-enabled-technology-and-healthcare-database

Leveraging comprehensive real-world data (RWD) and AI-enabled tools from PAS, TFS will gain enhanced capabilities to assess sit...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION